D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) CAS NO.: 6138-23-4

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) CAS 6138 23 4
AVT trehalose dihydrate (for injection) is commonly used in lyophilized protective agent, lipid nanoparticles and mRNA stabilizer and cryoprotectant. The quality of D(+)-Trehalose Dihydrate cas no 6138 23 4 is in line with trehalose dihydrate GMP, trehalose dihydrate USP, ChP, JP, EP standards. It's also highly cost-effective and suitable for use in injection-grade formulations. Registered with the US FDA, DMF No.034401 and 035566.

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) KEY BENEFITS
AVT introduces the specifications of trehalose dihydrate excipient like trehalose dihydrate molecular weight. It also can called alpha alpha trehalose dihydrate and crystalline trehalose dihydrate has many benefits.

Trehalose dihydrate excipient offers a highly cost-effective and injection-grade solution with an impressively low endotoxin level of less than 0.1 IU/g.

Comply with the national pharmacopeia standards, ChP, JP, EP, and our trehalose dihydrate also meet USP and GMP standards. The trehalose dihydrate GMP certification ensures that it meets the highest standards of quality and safety.

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) SPECIFICATIONS

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) PRODUCT PROPERTIES

Stronger hydration ability.

Higher glass transition temperature.

Resistance to high temperature and humidity.

As a pharma excipients company who is committed to pharmaceutical excipients wholesale, AVT ltd strives to advance the quality of existing excipients in pharmaceutical industry, as well as proactively develops niche pharma excipients, especially those of low-endotoxin and injectable used for biological drugs, liposomes, and fat emulsions, so as to help global pharmaceutical companies to develop high-quality medicines.